Digoxin is a medication that is used to treat congestive heart failure, atrial fibrillation, and other heart conditions. It belongs to the group of medications called cardiac glycosides. Digoxin is available in tablet form and injection form. Tablet product segment accounted for 57% of the global digoxin market share in 2018. The tablet product segment was followed by injection product with a share of 34%. The remaining 9% was attributed to tablet product had a market share of 68%. North America accounted for the largest regional market share in 2018 with a contribution of 45%. Europe followed North America with a contribution of 27%, while Asia Pacific contributed 18% and Latin America contributed 10%. Middle East & Africa accounted for 5% while it had no contribution from the rest of the world. The global digoxin market size was valued at USD 1,814 million in 2018 and is expected to reach USD 2,907 million by 2030, growing at an estimated CAGR of 7.2% during 2019-2030.
- The market for Digoxin is expected to grow due to the increasing number of patients with heart failure and atrial fibrillation.
Industry Growth Insights published a new data on “Digoxin Market”. The research report is titled “Digoxin Market research by Types (Purity Above 98%, Purity Below 98%, Purity: Greater than or equal to98% had a market share of 68% in 2018.), By Applications (Tablet Product, Injection Product, Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.), By Players/Companies C2 Pharma, Alkaloids Corporation, Vital Labs, Alchem”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Digoxin Market Research Report
By Type
Purity Above 98%, Purity Below 98%, Purity: Greater than or equal to98% had a market share of 68% in 2018.
By Application
Tablet Product, Injection Product, Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
By Companies
C2 Pharma, Alkaloids Corporation, Vital Labs, Alchem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Digoxin Market Report Segments:
The global Digoxin market is segmented on the basis of:
Types
Purity Above 98%, Purity Below 98%, Purity: Greater than or equal to98% had a market share of 68% in 2018.
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet Product, Injection Product, Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- C2 Pharma
- Alkaloids Corporation
- Vital Labs
- Alchem
Highlights of The Digoxin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity Above 98%
- Purity Below 98%
- Purity: Greater than or equal to98% had a market share of 68% in 2018.
- By Application:
- Tablet Product
- Injection Product
- Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digoxin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Digoxin is a medication used to treat heart failure, irregular heartbeats, and other conditions. It works by relaxing the muscles in the heart and preventing them from contracting too hard.
Some of the key players operating in the digoxin market are C2 Pharma, Alkaloids Corporation, Vital Labs, Alchem.
The digoxin market is expected to grow at a compound annual growth rate of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Digoxin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Digoxin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Digoxin Market - Supply Chain
4.5. Global Digoxin Market Forecast
4.5.1. Digoxin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Digoxin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Digoxin Market Absolute $ Opportunity
5. Global Digoxin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Digoxin Market Size and Volume Forecast by Type
5.3.1. Purity Above 98%
5.3.2. Purity Below 98%
5.3.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Digoxin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Digoxin Market Size and Volume Forecast by Application
6.3.1. Tablet Product
6.3.2. Injection Product
6.3.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Digoxin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Digoxin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Digoxin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Digoxin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Digoxin Demand Share Forecast, 2019-2026
9. North America Digoxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Digoxin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Digoxin Market Size and Volume Forecast by Application
9.4.1. Tablet Product
9.4.2. Injection Product
9.4.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Digoxin Market Size and Volume Forecast by Type
9.7.1. Purity Above 98%
9.7.2. Purity Below 98%
9.7.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Digoxin Demand Share Forecast, 2019-2026
10. Latin America Digoxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Digoxin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Digoxin Market Size and Volume Forecast by Application
10.4.1. Tablet Product
10.4.2. Injection Product
10.4.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Digoxin Market Size and Volume Forecast by Type
10.7.1. Purity Above 98%
10.7.2. Purity Below 98%
10.7.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Digoxin Demand Share Forecast, 2019-2026
11. Europe Digoxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Digoxin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Digoxin Market Size and Volume Forecast by Application
11.4.1. Tablet Product
11.4.2. Injection Product
11.4.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Digoxin Market Size and Volume Forecast by Type
11.7.1. Purity Above 98%
11.7.2. Purity Below 98%
11.7.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Digoxin Demand Share, 2019-2026
12. Asia Pacific Digoxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Digoxin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Digoxin Market Size and Volume Forecast by Application
12.4.1. Tablet Product
12.4.2. Injection Product
12.4.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Digoxin Market Size and Volume Forecast by Type
12.7.1. Purity Above 98%
12.7.2. Purity Below 98%
12.7.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Digoxin Demand Share, 2019-2026
13. Middle East & Africa Digoxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Digoxin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Digoxin Market Size and Volume Forecast by Application
13.4.1. Tablet Product
13.4.2. Injection Product
13.4.3. Tablet Product is the greatest segment of Digoxin application, with a share of 57% in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Digoxin Market Size and Volume Forecast by Type
13.7.1. Purity Above 98%
13.7.2. Purity Below 98%
13.7.3. Purity: Greater than or equal to98% had a market share of 68% in 2018.
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Digoxin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Digoxin Market: Market Share Analysis
14.2. Digoxin Distributors and Customers
14.3. Digoxin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. C2 Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alkaloids Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Vital Labs
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Alchem
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook